Literature DB >> 10436401

Long-term results of total parathyroidectomy without autotransplantation in patients with and without renal failure.

H Hampl1, T Steinmüller, P Fröhling, C Naoum, K Leder, U Stabell, N Schnoy, P M Jehle.   

Abstract

The optimal surgical procedure for severe renal secondary hyperparathyroidism (sHPT) is still a point of controversy. Total parathyroidectomy (PTX) without auto-transplantation was abandoned for fear of an adynamic bone condition; however, in the case of autotransplantation recurrent sHPT is frequent and promotes atherosclerosis. We studied 11 hemodialysis patients (age 59+/-12 years) on dialysis for 18 (12-30) years in whom total PTX was performed due to severe sHPT (group I; intact PTH: 1,240+/-230 pg/ml), and 5 patients (age 55+/-10 years) without renal insufficiency who inadvertently received total PTX during thyroid surgery (group II). After total PTX (group I, 26+/-18 [9-59] months; group II, 252+/-188 [22 480] months) both groups showed no measurable intact PTH levels. Calcium homeostasis was maintained by oral substitution with calcium (group I, calcium dialysate of 2.0 mmol/l), vitamin D and calcitriol (serum parameters in groups I and II: calcium 2.4 and 2.2 mmol/l; phosphate 1.8 and 1.1 mmol/l; 25(OH)-vitamin D(3) 21 and 34 ng/ml; 1,25(OH)(2)-vitamin D(3) 32 and 41 pg/ml, respectively). In group I, after total PTX there was a rapid and sustained improvement in bone pain with markedly enhanced physical activity and endurance. High turnover osteopathy markedly improved as indicated by declining levels of native osteocalcin (90+/-17 vs. 26+/-18 ng/ml), bone alkaline phosphatase (74+/-12 vs. 12+/-6 ng/ml), and carboxyterminal cross-linked telopeptide of type-I collagen (65+/-16 vs. 40+/-21 ng/ml) but increasing levels of carboxyterminal propeptide of type-I procollagen (120+/-36 vs. 148+/-41 ng/ml). Recalcification of bone was excellent as demonstrated by X-ray and confirmed by bone histology. Itching extravascular calcific deposits and calcifications of blood vessel and cardiac valves immediately stopped after total PTX. Moreover, 6 sHPT patients suffered from severe atherosclerotic lesions such as thoracic aortic aneurysm (n = 3) or abdominal aortic aneurysm (n = 3) which showed size progression before but not after total PTX when annually controlled by ultrasonography. In group II, even long after total PTX, there was no clinical, radiological, histological or biochemical evidence for low turnover osteopathy. In conclusion, our data indicate that substitution with vitamin D(3) metabolites and calcium can prevent deleterious bone effects of hypoparathyroidism in hemodialysis patients and in patients with normal kidney function and may compensate for the missing PTH action. Over this, a better survival rate is expected as a consequence of the beneficial effect of total PTX on the progression of atherosclerotic lesions. We suggest reconsideration of total PTX without autotransplantation in dialysis patients with severe sHPT who are not eligible for renal transplantation.

Entities:  

Mesh:

Year:  1999        PMID: 10436401     DOI: 10.1159/000057440

Source DB:  PubMed          Journal:  Miner Electrolyte Metab        ISSN: 0378-0392


  9 in total

1.  Initial parathyroid surgery in 606 patients with renal hyperparathyroidism.

Authors:  Ralph Schneider; Emily P Slater; Elias Karakas; Detlef K Bartsch; Katja Schlosser
Journal:  World J Surg       Date:  2012-02       Impact factor: 3.352

2.  Removal of autografted parathyroid tissue for recurrent renal hyperparathyroidism in hemodialysis patients.

Authors:  Yoshihiro Tominaga; Susumu Matsuoka; Nobuaki Uno; Toyonori Tsuzuki; Takahisa Hiramitsu; Norihiko Goto; Takaharu Nagasaka; Yoshihiko Watarai; Kazuharu Uchida
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

3.  Impact of intraoperative parathyroid hormone levels on surgical results in patients with renal hyperparathyroidism.

Authors:  Theresia Weber; Martin Zeier; Ulf Hinz; Tobias Schilling; Markus W Büchler
Journal:  World J Surg       Date:  2005-09       Impact factor: 3.352

4.  Total parathyroidectomy without autotransplantation after renal transplantation for tertiary hyperparathyroidism: long-term follow-up.

Authors:  Hazim M Sadideen; John D Taylor; David J Goldsmith
Journal:  Int Urol Nephrol       Date:  2011-10-14       Impact factor: 2.370

5.  Parathyroid subcutaneous pre-sternal transplantation after parathyroidectomy for renal hyperparathyroidism. Long-term graft function.

Authors:  Miguel Echenique-Elizondo; José Antonio Amondarain; Fernando Vidaur; Carmen Olalla; Fernando Aribe; Adolfo Garrido; José Molina; Maria Teresa Rodrigo
Journal:  World J Surg       Date:  2007-05-22       Impact factor: 3.352

6.  Once-weekly teriparatide in hemodialysis patients with hypoparathyroidism and low bone mass: a prospective study.

Authors:  K Sumida; Y Ubara; J Hoshino; K Mise; N Hayami; T Suwabe; M Kawada; A Imafuku; R Hiramatsu; E Hasegawa; M Yamanouchi; N Sawa; K Takaichi
Journal:  Osteoporos Int       Date:  2015-11-02       Impact factor: 4.507

Review 7.  Surgical and medical treatment of secondary hyperparathyroidism in patients on continuous dialysis.

Authors:  Yoshihiro Tominaga; Susumu Matsuoka; Nobuaki Uno
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

Review 8.  Mineral and bone disorder after renal transplantation: a review.

Authors:  Hazim Sadideen; Adrian Covic; David Goldsmith
Journal:  Int Urol Nephrol       Date:  2007-12-18       Impact factor: 2.370

9.  Comparison of total parathyroidectomy without autotransplantation and without thymectomy versus total parathyroidectomy with autotransplantation and with thymectomy for secondary hyperparathyroidism: TOPAR PILOT-Trial.

Authors:  Katja Schlosser; Johannes A Veit; Stefan Witte; Emilio Domínguez Fernández; Norbert Victor; Hans-Peter Knaebel; Christoph M Seiler; Matthias Rothmund
Journal:  Trials       Date:  2007-09-18       Impact factor: 2.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.